MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: a study on 939 patients - Trifa, A P; Bănescu, C; Bojan, A S (Am J Hematol, 2018)